These findings suggest that the anti-proliferative activity of DFX117 in cancer cells is in part correlated with the induction of G0/G1 cell cycle arrest via its regulation of the expression levels of proteins in the PI3K/Akt and c-Met pathways. Here, PIK3CA is linked to cancer.